NanoString Technologies, Inc.

    NanoString Technologies, Inc.

    NNASDAQ:NSTG
    0.11
    USD
    0.00
    (0.00%)
    2010 Y
    2011 Y
    2012 Y
    2013 Y
    2014 Y
    2015 Y
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    TTM
    Revenue per Share
    1.46
    1.94
    2.51
    4.11
    2.67
    3.29
    4.3
    4.84
    3.83
    3.63
    3
    3.2
    2.74
    3.44
    Basic EPS, GAAP
    -2.14
    -1.19
    -2.75
    -3.83
    -2.8
    -2.4
    -2.34
    -1.84
    -2.78
    -1.18
    -2.82
    -2.54
    -3.44
    -3.53
    Free Cash Flow per Basic Share
    -1.61
    -1.46
    -1.66
    -4.2
    -2.24
    -2.48
    -0.5
    -2.36
    -2.1
    -2.81
    -2.28
    -2.19
    -3.27
    -2.88
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    - -
    -7.58
    -10.23
    -16.59
    -9.91
    -11.69
    -13.4
    -13.19
    -14.03
    -12.49
    -13.87
    -14.34
    -17.44
    -19.75
    Tangible Book Value per Share
    - -
    -7.58
    -10.23
    4.12
    2.51
    1.06
    0.61
    1.69
    1.32
    3.01
    7.85
    3.91
    0.99
    -1.07
    Basic Weighted Avg Shares
    8
    9
    9
    8
    18
    19
    20
    24
    28
    35
    39
    45
    46
    47
    Sales/Revenue/Turnover
    12
    18
    23
    31
    48
    63
    86
    115
    107
    126
    117
    145
    127
    162
    Operating Margin (%)
    -110.59
    -58.97
    -71.86
    -90.75
    -96.7
    -65.81
    -47.61
    -33.24
    -65.02
    -65.86
    -75.05
    -74.59
    -119.58
    -100.07
    Depreciation Expense
    1
    1
    2
    2
    2
    2
    3
    3
    4
    5
    6
    6
    8
    14
    Net Income, GAAP
    -13
    -11
    -18
    -29
    -50
    -46
    -47
    -44
    -77
    -41
    -110
    -115
    -160
    -166
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    -108.85
    -61.42
    -77.08
    -93.24
    -105.14
    -72.74
    -54.45
    -37.91
    -72.52
    -32.41
    -93.83
    -79.44
    -125.37
    -102.44
    Working Capital
    - -
    12
    20
    42
    76
    62
    77
    86
    89
    168
    462
    375
    228
    134
    LT Debt
    - -
    1
    10
    12
    30
    41
    47
    49
    58
    109
    198
    247
    245
    242
    Total Equity
    - -
    12
    10
    31
    45
    20
    12
    40
    37
    104
    307
    177
    46
    -51
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -

    Capital Structure

    USD

    •

    in mil. unless spec.
    Mar'23
    Jun'23
    Sep'23
    ST Debt
    5
    5
    6
    LT Borrowings
    227
    227
    228
    LT Finance Leases
    17
    16
    14
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    47
    48
    48
    Market Capitalization
    462
    190
    81

    Working Capital

    USD

    •

    in mil. unless spec.
    Mar'23
    Jun'23
    Sep'23
    Total Current Assets
    252
    221
    212
    Cash, Cash Equivalents & STI
    155
    118
    97
    Accounts Receivable, Net
    35
    43
    48
    Inventories
    47
    49
    55
    Total Current Liabilities
    58
    62
    78
    Payables & Accruals
    27
    30
    43
    ST Debt
    5
    5
    6
    Deferred Revenue
    13
    14
    15

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    64.61%
    50.53%
    -74.11%
    Free Cash Flow
    65.67%
    25.33%
    52.9%
    Net Income, GAAP
    36.7%
    48.78%
    38.43%
    Sales/Revenue/Turnover
    20.62%
    3.07%
    -12.28%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2021
    32
    34
    37
    42
    145
    2022
    31
    32
    30
    34
    127
    2023
    36
    44
    48
    - -
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2021
    -0.62
    -0.6
    -0.69
    -0.64
    -2.54
    2022
    -0.86
    -0.85
    -0.79
    -0.95
    -3.44
    2023
    -0.88
    -0.92
    -0.78
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2021
    - -
    - -
    - -
    - -
    - -
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -

    Company Description

    Company Profile APIChatGPT
    Address
    Similar Companies
    Business

    Company News

    Company News APIChatGPT

    • geekwire.com

      Seattle biotech company NanoString to be acquired by Bruker for $392M, ending bankruptcy process

    • businesswire.com

      NanoString Products Drive Breakthrough Cancer Research at the 2024 American Association of Cancer Research (AACR) Conference

    • investorplace.com

      Why Is NanoString (NSTG) Stock Up 115% Today?

    • businesswire.com

      NanoString Announces Completion of Financing to Support Restructuring Process

    • investorplace.com

      Why Is NanoString (NSTG) Stock Up 180% Today?

    • investorplace.com

      Why Is NanoString Technologies (NSTG) Stock Down 59% Today?

    • businesswire.com

      NanoString Takes Steps to Restructure Its Business and Protect Its Mission to Map the Universe of Biology

    • businesswire.com

      NanoString Launches the CosMx 6,000 plex RNA Assay and Showcases Whole Transcriptome Imaging Capability

    • businesswire.com

      NanoString's CosMx SMI Achieves Whole Transcriptome Imaging at Single-Cell Resolution

    • geekwire.com

      NanoString Technologies to cut 9% of workforce, gets delisting notice from Nasdaq

    • businesswire.com

      NanoString Reports Inducement Grants Under Nasdaq Listing Rules

    • businesswire.com

      NanoString to Webcast Presentation from 42nd Annual J.P. Morgan Healthcare Conference

    • investorplace.com

      7 Nano-Cap Stocks That Pack a Serious Punch for Their Weight

    • businesswire.com

      NanoString Comments on Delaware District Court Verdict

    • prnewswire.com

      10x Genomics Wins Another Patent Infringement Case Against NanoString Technologies

    • businesswire.com

      NanoString Technologies to Present Portfolio of Cutting-edge Brain Research and Novel Spatial Biology Applications for Neuroscience

    • businesswire.com

      NanoString to Webcast Presentations from Upcoming Healthcare Conferences

    • seekingalpha.com

      NanoString Technologies, Inc. (NSTG) Q3 2023 Earnings Call Transcript

    • zacks.com

      NanoString (NSTG) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

    • businesswire.com

      NanoString Technologies Releases Operating Results for Third Quarter of 2023